名稱 | BCR-ABL1 G250E/BaF3 |
型號(hào) | CBP73321 |
報(bào)價(jià) | ![]() |
特點(diǎn) | BCR-ABL1 [G250E]/BaF3 |
產(chǎn)品搜索
相關(guān)文章
- 有關(guān)細(xì)胞株生長(zhǎng)要考慮的因素
- RNA-Fusion Cocktail再升級(jí)
- 談?wù)勀[瘤細(xì)胞為何對(duì)抑制生長(zhǎng)信號(hào)不敏感
- 降糖&減肥明星靶點(diǎn):GLP1R/GIPR/GCGR
- 【產(chǎn)品推介】胰高血糖素受體藥物細(xì)胞篩選模型
- NK2R細(xì)胞篩選模型
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- NIPT標(biāo)準(zhǔn)品-助力無創(chuàng)產(chǎn)前檢測(cè)
- 大腦中新發(fā)現(xiàn)的一種淋巴細(xì)胞,能夠清除大腦廢物
- IHC第三方質(zhì)控品——病理質(zhì)控基石,精準(zhǔn)診斷起點(diǎn)
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73321BCR-ABL1 G250E/BaF3

- 詳細(xì)內(nèi)容
CBP73321 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [G250E]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1.WB of BCR-ABL1 [G250E]/BaF3 | |
2.Sanger of BCR-ABL1 [G250E]/BaF3 Figure 2. BCR-ABL1 [G250E]/BaF3 G250E Figure 3. BCR-ABL1 [G250E]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 G250E Cells (C3). | |